{"entity":{"type":"insider","cik":"0001934232","url":"/insider/0001934232","json_url":"/insider/0001934232.json","name":"Powl Brian T.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2023-07-06","last":"2026-05-22","span_basis":"filed_date"},"name_variants":[{"name":"Powl Brian T.","source":"filing","n_filings":7,"first_seen":"2023-07-06","last_seen":"2026-05-22"}],"transactions":[{"id":6196253,"accession":"0001193125-26-236838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-236838","line_url":"/filing/0001193125-26-236838#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001934232","owner_name":"Powl Brian T.","owner_display_name":"Powl Brian T.","owner_url":"/insider/0001934232","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":110000.0,"total_display":"110,000.00","total_whole":"110,000","shares_owned_after":173614.0,"shares_owned_after_display":"173,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-21","filed_date":"2026-05-22","scope":"insider"},{"id":5894509,"accession":"0001193125-26-232547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-232547","line_url":"/filing/0001193125-26-232547#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001934232","owner_name":"Powl Brian T.","owner_display_name":"Powl Brian T.","owner_url":"/insider/0001934232","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":339.0,"shares_display":"339","price_per_share":9.21,"price_display":"9.21","price_state":"stated","total_value":3122.19,"total_display":"3,122.19","total_whole":"3,122","shares_owned_after":183614.0,"shares_owned_after_display":"183,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-20","scope":"insider"},{"id":5745138,"accession":"0001193125-26-025305","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-025305","line_url":"/filing/0001193125-26-025305","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001934232","owner_name":"Powl Brian T.","owner_display_name":"Powl Brian T.","owner_url":"/insider/0001934232","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6414.0,"shares_display":"6,414","price_per_share":8.46062450888681,"price_display":"8.46","price_state":"stated","total_value":54266.4456,"total_display":"54,266.45","total_whole":"54,266","shares_owned_after":184847.0,"shares_owned_after_display":"184,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-27","filed_date":"2026-01-27","scope":"insider","n_lines":2},{"id":4672911,"accession":"0001193125-25-283564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-283564","line_url":"/filing/0001193125-25-283564#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001934232","owner_name":"Powl Brian T.","owner_display_name":"Powl Brian T.","owner_url":"/insider/0001934232","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8887.0,"shares_display":"8,887","price_per_share":11.1769,"price_display":"11.18","price_state":"stated","total_value":99329.1103,"total_display":"99,329.11","total_whole":"99,329","shares_owned_after":139689.0,"shares_owned_after_display":"139,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-14","filed_date":"2025-11-14","scope":"insider"},{"id":4754713,"accession":"0001193125-25-223667","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-223667","line_url":"/filing/0001193125-25-223667#line-2","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001934232","owner_name":"Powl Brian T.","owner_display_name":"Powl Brian T.","owner_url":"/insider/0001934232","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8891.0,"shares_display":"8,891","price_per_share":8.9422,"price_display":"8.94","price_state":"stated","total_value":79505.1002,"total_display":"79,505.10","total_whole":"79,505","shares_owned_after":99676.0,"shares_owned_after_display":"99,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-09-29","scope":"insider"},{"id":4027180,"accession":"0000950170-25-010116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-010116","line_url":"/filing/0000950170-25-010116#line-1","is_derivative":false,"issuer_cik":"0001422143","issuer_name":"Kura Oncology, Inc.","issuer_ticker":"KURA","issuer_name_source":null,"issuer_url":"/issuer/0001422143","owner_cik":"0001934232","owner_name":"Powl Brian T.","owner_display_name":"Powl Brian T.","owner_url":"/insider/0001934232","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1583.0,"shares_display":"1,583","price_per_share":7.8719,"price_display":"7.87","price_state":"stated","total_value":12461.2177,"total_display":"12,461.22","total_whole":"12,461","shares_owned_after":59667.0,"shares_owned_after_display":"59,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-28","scope":"insider"},{"id":8500892,"accession":"0001209191-23-041611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041611","line_url":"/filing/0001209191-23-041611#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001934232","owner_name":"Powl Brian T.","owner_display_name":"Powl Brian T.","owner_url":"/insider/0001934232","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3854.0,"shares_display":"3,854","price_per_share":4.87,"price_display":"4.87","price_state":"stated","total_value":18768.98,"total_display":"18,768.98","total_whole":"18,769","shares_owned_after":41146.0,"shares_owned_after_display":"41,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-05","filed_date":"2023-07-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001422143","name":"Kura Oncology, Inc.","url":"/issuer/0001422143","role":"Officer (Chief Commercial Officer)","n_filings":6,"first_seen":"2025-01-28","last_seen":"2026-05-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Officer (Chief Commercial Officer)","n_filings":1,"first_seen":"2023-07-06","last_seen":"2023-07-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001934232","retrieved_at":"2026-08-22T17:51:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}